The Amgen of 2027 could be much be larger than some investors expect.
The gold rush for obesity medications just got a bit more intense.
USA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly in...
Eli Lilly's biggest growth drivers today are its weight loss drugs.
Through its long history, the Dow Jones Industrial Average has offered a way for people to get a quick read on how Wall Street is doing
Amgen has outperformed the broader market and many of its peers over the past year, but Wall Street analysts believe it has limited upside left.
Could Amgen be the next stock to soar due to a GLP-1 drug?
/CNW/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can...
USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can accurately detect early-stage pancreatic cancer with...
The biotech's pipeline extends far beyond this exciting weight-loss product.